The Recall Desk
SevereFDA (Drugs)·D-714-2015·Announced 2015-04-29

Attix Pharmaceuticals Recalls Hydrocortisone Base Due to Penicillin Cross-Contamination Risk

Attix Pharmaceuticals is recalling all lots of hydrocortisone base active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to potential penicillin cross-contamination.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves a high-risk allergen (penicillin) cross-contamination, which meets the criteria for a Severe rating due to the potential for significant injury.

Plain-English summary

Attix Pharmaceuticals is recalling all lots of hydrocortisone base active pharmaceutical ingredient. The product was packaged in varying grams or kilograms in bags or drums. The recall covers all lots repackaged and distributed between January 5, 2012, and February 12, 2015.

The recall was initiated because the product was repackaged in a facility that also handled penicillin products without adequate separation. This process created a potential for cross-contamination with penicillin. The FDA has classified this recall as Class II.

The affected product was distributed nationwide to compounding pharmacies and research organizations. Consumers and healthcare providers should check their inventory for hydrocortisone base from Attix Pharmaceuticals with distribution dates within the specified range and stop using it if found.

The recalled product

Product
Hydrocortisone base active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots repackaged and distributed between 01/05/12 to 02/12/15

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 470 recalled by Attix Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 470 products in this recall →